Canadian Network for Vaccines and Immunotherapies

The Canadian Network for Vaccines and Immunotherapies (CANVAC) was a prominent national research network established under Canada's Networks of Centres of Excellence (NCE) program. Operating from 1999 to 2009, the organization was headquartered in Montreal and focused on accelerating the development of innovative vaccines and immunotherapies for chronic viral diseases and cancer. CANVAC brought together a multidisciplinary team of over 70 world-class researchers from across Canadian universities and hospitals to collaborate on high-impact projects. Its primary research pillars included HIV/AIDS, Hepatitis C, and cancer immunotherapy, with several programs advancing into early-stage clinical trials. The network played a crucial role in fostering academic-industry partnerships and training the next generation of scientists in the Canadian biotechnology sector. Following the completion of its federal funding cycle, the network's activities were integrated into other research initiatives.